Meltzer H Y, Duncavage M B, Jackman H, Arora R C, Tricou B J, Young M
Am J Psychiatry. 1982 Oct;139(10):1242-8. doi: 10.1176/ajp.139.10.1242.
The authors determined the platelet MAO activity of 57 psychotic patients after a placebo period and after 3-65 days of neuroleptic treatment. Platelet MAO activity significantly decreased in both men and women after neuroleptic treatment. The platelet MAO activity of neuroleptic-treated schizophrenic women was significantly less than that of drug-free schizophrenic women, who did not differ from normal women. There were trends in the same direction for the schizophrenic men. Previous studies that reported lower platelet MAO activity in neuroleptic-treated schizophrenic patients than in normal controls may have been influenced by this neuroleptic effect.
作者测定了57例精神病患者在安慰剂期及接受抗精神病药物治疗3 - 65天后的血小板单胺氧化酶(MAO)活性。抗精神病药物治疗后,男性和女性的血小板MAO活性均显著降低。接受抗精神病药物治疗的精神分裂症女性的血小板MAO活性显著低于未服用药物的精神分裂症女性,而未服用药物的精神分裂症女性与正常女性无差异。精神分裂症男性也有相同方向的趋势。先前报道抗精神病药物治疗的精神分裂症患者血小板MAO活性低于正常对照组的研究可能受到了这种抗精神病药物效应的影响。